当前位置: 首页 > 期刊 > 《中国现代医生》 > 2017年第8期
编号:13064259
小剂量激素耐药的难治性支原体肺炎临床危险因素分析(4)
http://www.100md.com 2017年3月15日 《中国现代医生》 2017年第8期
     [10]王雷,段建华. 68 例小儿难治性肺炎支原体肺炎临床分析[J]. 中华实验和临床病毒学杂志,2011,25(3):224-226.

    [11]张清友,王秀丽,杜军保,等.儿童重症肺炎支原体肺炎临床特征及激素治疗疗效分析[J].中国实用儿科杂志,2011,26(3):223-224.

    [12]Akihiro Tamura,Kousaku Matsubara,Takayuki Tanaka,et al. Methylprednisolone pulse therapy for refractory Mycoplasma pneumoniae pneumonia in children[J]. Journal of Infection, 2008,(3):223-228

    [13]You SY,Jwa HJ,Yang EA,et al. Effects of Methylprednisolone Pulse Therapy on Refractory Mycoplasma pneumoniae Pneumonia in Children[J]. Allergy Asthma Immunol Res,2014,6(1):22-26.

    [14]Hsieh YC,Tsao KC,Huang CG,et al. Life-threatening pneumonia caused by macrolide-resistant Mycoplasma pneumonia[J]. The Pediatric Infectious Disease Journal, 2012,31(2):208-209.

    [15]陳志敏. 合理治疗难治性肺炎支原体肺炎[J].中华儿科杂志, 2013, 51(10): 724-728.

    [16]Inamura N,Miyashita N,Hasegawa S,et al. Management of refractory Mycoplasma pneumoniae pneumonia:Utility of measuring serum lactate dehydrogenase level[J]. Journal of Infection and Chemotherapy,2014,20(4):270-273., 百拇医药(张倩 周格)
上一页1 2 3 4